HACD2 and pachyonychia congenita: Similarly, the findings from the tissue chip indicated that HACD2 was highly expressed in PC tumors, particularly in stage II patients, and those with elevated HACD2 expression were more likely to have a poor prognosis (Figure 1C; and Table S1, Supporting information).